Charles  |  AGE 32

  • Existing Schizophrenia Dx
  • On oral AP
  • Adherence concerns/history of nonadherence
Back to Scenario List

Outpatient Setting | Scenario 9

LAI Considerations

  • Discuss LAI of the oral antipsychotic whose tolerability/exposure has been established to improve adherence in the future
    13,18
  • It is human nature to have difficulty taking medication on a long-term basis, regardless of the illness and medication type
    14,29
  • When presenting LAIs as a treatment option include in the discussion information about efficacy and convenience
    12,30
  • LAI use may take the burden from family/caregiver monitoring of patient adherence and would help clinicians assess whether relapse occurs because of nonadherence or despite adequate medication
    19,23
Additional Considerations for LAIs
References
© 2024 Teva Neuroscience, Inc.  |  
tv46-US-NP-00067 May 2023